| ψm | mitochondrial membrane potential |
| ADC | antibody–drug conjugates |
| AR-V7 | androgen receptor splice variant V7 |
| AR-FL | androgen receptor-full length |
| AR | androgen receptor |
| ARTA | androgen receptor targeting therapy |
| CCCP | carbonyl cyanide m-chlorophenyl hydrazine |
| CI | combinational index |
| CRPC | castration-resistant prostate cancer |
| DMSO | dimethylsulfoxide |
| dsDNA | double-strand DNA |
| ssDNA | single-strand DNA |
| FACS | fluorescence-activated cell sorting |
| HDAC | histone deacetylase |
| HRR | homologous recombination repair mechanisms |
| MAPK | mitogen-activated protein kinase |
| MAPKi | MAP kinases inhibitor |
| mCRPC | metastatic castration-resistant prostate cancer |
| NaC | N-acetyl-L-cysteine |
| PCa | prostate cancer |
| PI | propidium iodide |
| PSA | prostate-specific antigen |
| ROS | reactive oxygen species |
| SAR | structure–activity relationships |
| SAPK | stress-activated protein kinase |
| zVAD | z-VAD(OMe)-fmk (pan-caspase inhibitor). |